Pulse Biosciences Announces First CellFX® Procedure Performed in Canada

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced that the first patient in Canada has been treated with the CellFX procedure. The first commercial use in Canada of the cellular-focused CellFX System proven to...

Click to view original post